Trials / Completed
CompletedNCT02434835
Study of Absorption, Metabolism and Excretion Following a Single Oral Dose of [14C]KWA-0711 to Healthy Male Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- —
- Sponsor
- Kissei Pharmaceutical Co., Ltd. · Industry
- Sex
- Male
- Age
- 35 Years – 55 Years
- Healthy volunteers
- —
Summary
The purpose of this study is to evaluate the absorption, metabolism and excretion following a single oral dose of \[14C\]KWA-0711 to healthy male subjects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | [14C]KWA-0711 |
Timeline
- Primary completion
- 2015-05-01
- First posted
- 2015-05-05
- Last updated
- 2016-04-18
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT02434835. Inclusion in this directory is not an endorsement.